First Foundation Advisors Insulet Corp Transaction History

First Foundation Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$186.4 - $279.02 $1,118 - $1,674	-6 Reduced 0.51%	1,181 $257,000
Q1 2022 May 05, 2022	BUY	$194.8 - $275.7 $50,453 - $71,406	259 Added 27.91%	1,187 $316,000
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $12,766 - $15,914	50 Added 5.69%	928 $247,000
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $35,929 - $42,403	138 Added 18.65%	878 $250,000
Q2 2021 Aug 13, 2021	BUY	$225.52 - $304.06 $166,884 - $225,004	740 New	740 $203,000

730

63.2M

630K

854K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.8B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.